Cells must be capable of switching between growth and autophagy in unpredictable nutrient environments. The conserved Npr2 protein complex (comprising Iml1, Npr2, and Npr3; also called SEACIT) inhibits target of rapamycin complex 1 (TORC1) kinase signaling, which inhibits autophagy in nutrient-rich conditions. In yeast cultured in media with nutrient limitations that promote autophagy and inhibit growth, loss of Npr2 enables cells to bypass autophagy and proliferate. We determined that Npr2-deficient yeast had a metabolic state distinct from that of wild-type yeast when grown in minimal media containing ammonium as a nitrogen source and a nonfermentable carbon source (lactate). Unlike wild-type yeast, which accumulated glutamine, Npr2-deficient yeast metabolized glutamine into nitrogen-containing metabolites and maintained a high concentration of S-adenosyl methionine (SAM). Moreover, in wild-type yeast grown in these nutrient-limited conditions, supplementation with methionine stimulated glutamine consumption for synthesis of nitrogenous metabolites, demonstrating integration of a sulfur-containing amino acid cue and nitrogen utilization. These data revealed the metabolic basis by which the Npr2 complex regulates cellular homeostasis and demonstrated a key function for TORC1 in regulating the synthesis and utilization of glutamine as a nitrogen source.
INTRODUCTION
Metabolism is closely regulated according to nutrient availability. During nutrient sufficiency, metabolism provides anabolic substrates and energy for growth, whereas during starvation, processes such as autophagy provide a nutrient salvaging function (1, 2) . Imbalanced metabolic regulation can result in unchecked cell growth, as in cancer (3) (4) (5) . In eukaryotes, the target of rapamycin complex 1 (TORC1) pathway is a central nutrient-sensitive regulator of cell growth that responds to the abundance of amino acids (6) (7) (8) (9) (10) . The conserved Rag family of guanosine triphosphatases (GTPases) (11) (12) (13) , called Gtr1 and Gtr2 in yeast (13) , regulate cell growth by activating TORC1. Rag GTPases are closely associated with the lysosome or vacuole as part of larger amino acid-sensing systems (11, 13) .
A conserved protein complex consisting of Iml1, Npr2, and Npr3 (called the Npr2 complex or SEACIT in yeast, or GATOR1 in mammals) is at the hub of amino acid sensing and regulation of cell growth. Npr2 and Npr3 were first identified in Saccharomyces cerevisiae yeast as inhibitors of TORC1 activity that respond to changes in the abundance of available nitrogen and amino acids (14) (15) (16) . The Npr2 complex is part of a larger, vacuole-associated complex (called the SEA complex) (17, 18) . Studies from yeast and mammalian cells show that the SEA complex, through the Npr2 complex, inhibits the Gtr1 and Gtr2 or RagA and RagB GTPases, which then inhibit TORC1 (19, 20) . Previously, we observed that wild-type yeast induce autophagy when switched from rich media to minimal media containing lactate as the sole carbon source (18) . Yeast lacking any component of the Npr2 complex escape autophagy induced by minimal media with lactate and instead proliferate at a faster rate (18, 21) . This observation is consistent with the idea that the mammalian ortholog of Npr2, Nprl2, may be a tumor suppressor (22) (23) (24) .
Here, we characterized metabolic differences in Npr2-deficient yeast that enable them to continue proliferating in conditions in which wild-type yeast induce autophagy. Our results revealed the consequences of loss of this negative regulator of TORC1 in such a nutrient environment, which led to increased S-adenosyl methionine (SAM) availability and glutamine consumption for the synthesis of nitrogenous metabolites. These findings begin to explain how the Npr2 complex regulates the TORC1 pathway to alter metabolic homeostasis in response to particular nutrient limitations.
RESULTS

Wild-type and npr2D yeast grown in minimal lactate media have different metabolic profiles
To understand the role of the Npr2 complex in governing metabolic changes in response to nutrient deprivation, we profiled metabolites in wild-type and Npr2-deficient yeast (npr2D yeast) switched from a rich medium containing lactate as the carbon source (YPL) to minimal medium without amino acids and containing lactate (SL). Ammonium sulfate was the sole nitrogen source in SL. These conditions require increased oxidative metabolism for growth, and therefore may help reveal the contributions of regulatory pathways that may be subject to glucose repression (25, 26) . Wild-type and npr2D yeast grow at comparable rates in YPL (21) . However, as previously shown (21) , npr2D yeast grew faster than wild-type yeast when switched from YPL to SL (Fig. 1A) , suggesting that npr2D yeast bypassed autophagy. Integration of Npr2-FLAG into npr2D yeast inhibited growth in SL (Fig. 1A) , suggesting that unchecked proliferation was not due to the accumulation of suppressor mutations. In contrast, npr2D yeast grew slower than wild-type yeast when cultured in typical minimal media with glucose and ammonium (SD) (fig. S1), consistent with published studies (14, 15) .
We measured the relative abundances of intracellular metabolites covering major metabolic pathways in wild-type and npr2D yeast at several time points after switching from YPL to SL using liquid chromatography and targeted tandem mass spectrometry (LC-MS/MS) ( Fig. 1B and table S1 ). Both the direction and magnitude of changes of several metabolites were distinct in wild-type and npr2D yeast (Fig. 1B) , with several clusters of metabolites being anticorrelated (Fig. 1B and table S1 ).
npr2D yeast increase nitrogen assimilation and glutamine consumption for metabolite biosynthesis
We investigated which specific metabolites explained the absence of autophagy and increased proliferation of npr2D yeast. Leucine and isoleucine activate growth (13, 27) . However, we found that the abundance of these amino acids was lower in npr2D yeast than in wild-type yeast ( fig.  S2 and table S1), suggesting that there are alternative growth-inducing metabolic signals in npr2D yeast. In contrast, the abundance of glutamine increased in wild-type yeast more than 50-fold after 3 hours in SL but remained low in npr2D yeast ( Fig. 2A) , suggesting that npr2D yeast either rapidly consumed glutamine or had reduced glutamine synthesis in SL.
In yeast grown in media with poor carbon sources, such as lactate, Gdh2 promotes the conversion of glutamine to a-ketoglutarate for anaplerosis to replenish TCA (tricarboxylic acid) cycle intermediates or for oxidative ATP (adenosine triphosphate) synthesis (28, 29) (Fig. 2B) . After switching yeast from YPL to SL, a-ketoglutarate initially became more abundant in npr2D yeast than in wild-type yeast ( fig. S3 ), but at 4.5 hours in SL, a-ketoglutarate was increased in wild-type yeast but decreased in npr2D yeast ( fig. S3 ). npr2D yeast lacking Gdh2 grew at the same rate as npr2D yeast when cultured in SL ( fig. S4 ). Thus, npr2D cells did not require glutamine-dependent anaplerosis for growth in SL.
Glutamine is a critical nitrogen donor or substrate for nucleotide (30) , glutathione (31) , and nicotinamide adenine dinucleotide (NAD + ) biosynthesis (32) (Fig. 2B) , all of which may be important in proliferating cells (28) . The abundances of glutathione and NAD + were substantially higher in npr2D yeast than in wild-type yeast when grown in SL (Fig.  2C and table S1 ). Furthermore, whereas the abundances of nucleosides were decreased in npr2D yeast compared to wild-type yeast in SL, the abundances of nucleotides were substantially increased ( Fig. 2C and table S1), consistent with the prediction that npr2D yeast consumed nucleosides to sustain nucleotide synthesis required for proliferation in SL. To test this prediction, we measured the growth of npr2D yeast with deletions of genes encoding proteins involved in nucleotide synthesis. Individual deletion of genes encoding two complementary de novo purine biosynthesis enzymes, Ade16 and Ade17, did not affect the growth of wild-type yeast (33) (fig. S5 ). However, npr2D ade16D, but not npr2D ade17D, yeast had reduced proliferation compared to npr2D yeast in SL ( fig. S5 ).
These data suggested that npr2D yeast grown in SL increased ammonium assimilation and conversion into glutamine as a precursor for the synthesis of nitrogenous metabolites. To directly test this hypothesis, we switched (Fig. 2D and fig. S6 ). The relative abundances of these 15 N-labeled metabolites were increased more than 1000-fold in npr2D yeast compared to wild-type yeast (Fig. 2D) . We simultaneously measured unlabeled metabolites, enabling estimates of the ratio of newly synthesized to existing pools. In contrast to wild-type yeast, a large fraction of the total abundances of these metabolites were 15 N-labeled in npr2D yeast (Fig. 2E) . Thus, npr2D yeast grown in SL increased ammonium assimilation to synthesize nitrogenous metabolites important for growth.
To directly determine if npr2D yeast consumed glutamine for synthesis of nitrogenous metabolites, we switched yeast from YPL to SL supplemented with 15 N glutamine. We measured the abundances of 15 N labeled metabolites in which nitrogen was directly donated by glutamine, and excluded metabolites in which nitrogen was indirectly derived from glutamine ( fig. S6 ). The abundance of 15 N-containing species for these metabolites was markedly increased in npr2D yeast relative to wild-type yeast in these conditions (Fig. 3A) .
Thus, we tested whether the growth of npr2D yeast in SL was dependent on glutamine synthesis and consumption. The glutamate dehydrogenase enzymes Gdh1 and Gdh3 convert a-ketoglutarate to glutamate, which is then converted to glutamine (Fig.  2B) (34, 35) . Deletion of GDH1 (gdh1D) almost completely blocked proliferation of npr2D yeast in SL (Fig. 3B) , whereas deletion of GDH1 only led to a statistically significant but small reduction in growth of wild-type yeast during the period measured (Fig. 3C) . Deletion of GDH3 (gdh3D) slowed the growth of npr2D yeast in SL to a lesser degree than did deletion of GDH1 ( fig. S7A ). Supplementing SL with glutamine, but not cell-permeable a-ketoglutarate, increased the rate of growth of npr2D gdh1D yeast (Fig.  3B) , presumably enabling proliferation until the glutamine in the medium was depleted. In contrast, supplementing SL with glutamine did not increase the growth of wildtype yeast in SL ( fig. S7 ), suggesting that the ability to consume glutamine and not glutamine availability controls cell proliferation in these conditions.
The glutamate synthase Glt1 converts a-ketoglutarate and glutamine to glutamate (36, 37) . Deletion of GLT1 (glt1D) produced a small but statistically significant decrease in the growth of npr2D yeast in SL ( fig. S3B ), suggesting that Glt1 only plays a small role in the proliferation of npr2D yeast in these conditions.
Yeast cells adapt to nitrogen availability by altering gene expression. In media with preferred nitrogen sources, such as glutamine, yeast repress the expression of genes encoding enzymes associated with the use of nonpreferred nitrogen sources through a process known as nitrogen catabolite repression (30, 34, 38) . In media with poor nitrogen sources, such as ammonium, yeast increase glutamine by increasing the expression of genes encoding enzymes involved in glutamine metabolism, including Gdh1 and Gln1 (30, 34, 38, 39) . Therefore, we directly monitored the abundance of Gdh1 or Gln1 tagged with a FLAG epitope at the endogenous locus in wild-type and npr2D yeast. The abundance of Gdh1-FLAG and Gln1-FLAG increased in npr2D yeast, but not in wild-type yeast, switched from YPL to SL (Fig. 3D) .
We also examined the regulation of the transcription factor Gln3, which is activated during nitrogen starvation (10, 38, 40) . The responses of Gln3 to changes in nitrogen availability are complex (40, 41) , but in media containing preferred nitrogen sources, Gln3 is typically inactivated by hyperphosphorylation, which occurs in part by a TORC1-dependent mechanism (10, 30, 38, (40) (41) (42) (43) (44) . We therefore monitored gel mobility of Gln3-FLAG as an indicator of phosphorylation state. In YPL, the apparent molecular weight of Gln3 in both wild-type and npr2D yeast was decreased by inhibition of TORC1 with rapamycin ( Fig. 3E) , suggesting a high degree of basal phosphorylation of Gln3 in YPL. Moreover, when wild-type yeast were switched to SL, Gln3 phosphorylation immediately decreased and then recovered ( Fig. 3E ), suggesting that Gln3 became hyperphosphorylated as glutamine concentrations increased. In contrast, in npr2D yeast, Gln3 phosphorylation did not increase to the same extent over time in SL (Fig. 3E) . Thus, these data suggest that npr2D yeast bypass normal nitrogen-sensing mechanisms in SL owing to changes in proteins involved in glutamine biosynthesis.
Methionine promotes glutamine consumption for nitrogenous metabolite biosynthesis
Previously, we reported that wild-type yeast grown in SL have limited ability to synthesize sulfur-containing amino acid metabolites (21) . The addition of either methionine or its downstream metabolite SAM is sufficient to inhibit autophagy in SL (21) . Here, we found that the abundances of SAM and cysteine were increased in npr2D yeast relative to wild-type yeast when switched from YPL to SL (Fig. 4A and table S1 ). Furthermore, addition of methionine increased the proliferation of wild-type yeast in SL (Fig. 4B) , suggesting that methionine might promote glutamine consumption for nitrogen.
Relative protein amount Graph of the growth of yeast with the indicated genotypes cultured in SL with or without supplemental glutamine (0.5 mM) or a-ketoglutarate (cell-permeable ester, 2 mM). n =3; means ± SD. ***P < 0.001, unpaired t tests. (C) Graph of the growth of WT and gdh1D yeast in SL. Data are means ± SD of three experiments. *P < 0.05, unpaired t test. (D) Representative Western blots of lysates from WT or npr2D yeast expressing Gdh1-FLAG or Gln1-FLAG switched from YPL to SL for the specified times. Graphs represent the means ± SD of three blots from independent experiments. Proteins were normalized to total protein (Commassie stain) and then to WT at 0. *P < 0.05, ***P < 0.001, multiple t tests. (E) Western blot of WT or npr2D yeast expressing Gln3-FLAG grown in YPL with or without rapamycin (100 nM) for 20 min or switched to SL and collected at the indicated times. Increased apparent molecular weight indicates increased phosphorylation. The blot is representative of three independent experiments.
To test this hypothesis, we switched wild-type yeast from YPL to SL containing , and nucleotides were substantially increased compared to those in media without supplemental methionine (Fig. 4C) , and large fractions of the total pools of these metabolites were newly synthesized (Fig. 4D) . Similarly, in SL with 15 N-glutamine, the abundances of 15 N-containing metabolites that are direct recipients of nitrogen from glutamine were increased in yeast grown with supplemental methionine (fig. S8) .
We also compared the ability of methionine and glutamine to inhibit autophagy in wild-type and npr2D yeast. We evaluated autophagy by measuring the abundance of low-molecular weight ("free") green fluorescent protein (GFP) in yeast expressing GFP fused to Idh1 (Idh1-GFP), which is cleaved during autophagy (18, 45) . Culturing wild-type yeast in SL medium increased the cleavage of Idh1-GFP, and this effect was inhibited by adding methionine, but not glutamine (Fig. 4E) . However, supplementation with glutamine or methionine alone did not inhibit Idh1-GFP cleavage in wild-type yeast grown in SL lacking any nitrogen source (SL-N) (Fig. 4E) , suggesting both methionine and nitrogen deficits under SL-N conditions. In contrast, in npr2D yeast, increased Idh1-GFP cleavage indicative of increased autophagy was observed only in SL-N, which was partially rescued by adding glutamine or methionine alone and almost completely rescued by adding both glutamine and methionine (Fig. 4E) . These data suggest that even when a preferred nitrogen source such as glutamine is present, wild-type cells need sufficient methionine and SAM to avoid inducing autophagy, and that yeast lacking Npr2 have increased SAM and can bypass autophagy with a less favorable nitrogen source such as ammonium.
Previously, we found that methionine inhibits autophagy by promoting the methylation of the phosphatase PP2A by the methyltransferase Ppm1 (21) . Methylated PP2A dephosphorylates Npr2 and thereby inhibits the Npr2 complex (21) . In addition, PP2A targets many other substrates, including components of TORC1 (10) . Thus, we tested the extent to which methylated PP2A contributes to growth of cells lacking Npr2. We observed that double mutant npr2D ppm1D yeast proliferated slower than npr2D yeast in SL (Fig. 4F) . ppm1D yeast also proliferated slower than wildtype yeast in SL (Fig. 4F) . Thus, because PP2A is the primary substrate of Ppm1 (21, 46) , these data suggest that methylated PP2A dephosphorylates substrates other than Npr2 that contribute to growth in SL (Fig. 4F) . The rewiring of metabolism in npr2D yeast promoted growth in SL media through the combined effects of increased SAM, which Data are means ± SD of three experiments. **P < 0.01, ***P < 0.001, unpaired t test.
increased methylation of PP2A, and increased utilization of glutamine as a nitrogen donor.
Changes in metabolism in npr2D yeast require TORC1 activity
Because the Npr2 complex negatively regulates TORC1 (14, 19, 20) , we tested if the metabolic differences in npr2D yeast required TORC1 activity. We found that the differences in the abundances of most metabolites between wild-type and npr2D yeast switched from YPL to SL were largely abolished by exposure to a sublethal concentration of rapamycin (Fig. 5A) . Unlike in the absence of rapamycin ( Fig. 2A) , in the presence of rapamycin, the abundance of glutamine steadily increased in npr2D yeast in SL, in a manner similar to wild-type yeast (Fig. 5B) . Furthermore, the abundance of SAM, which was increased in the absence of rapamycin in npr2D yeast (Fig. 4A) , remained similar to or lower in npr2D yeast than in wild-type yeast in rapamycin-containing SL (Fig. 5B) . Thus, these data suggest that most metabolic differences caused by the absence of Npr2 were TORC1-dependent.
Wild-type yeast expressing constitutively active Gtr1 mimic the growth and metabolic phenotypes of npr2D yeast
The Npr2 complex functions as a GTPase-activating protein (GAP) for the Rag GTPase Gtr1 (19) , and the GTP-bound form of Gtr1 activates TORC1 (13) . To determine whether activation of Gtr1 was sufficient to induce metabolic and proliferative changes in SL similar to deletion of NPR2, we stably expressed constitutively active, GTP-bound Gtr1 (Gtr1-Q65L), which promotes constitutive activation of TORC1 (13, 47) . Expressing Gtr1-Q65L in wild-type yeast increased proliferation in SL (Fig. 6A) , whereas expressing Gtr1-Q65L in npr2D yeast did not further enhance proliferation in SL (Fig. 6A) . Moreover, the abundance of glutamine was decreased (Fig. 6B ) and the abundances of NAD + and glutathione were increased (Fig. 6C) by Gtr1-Q65L expression in wild-type yeast in SL. Likewise, Gtr1-Q65L expression increased the rate of recovery of the abundances of SAM and cysteine in wild-type yeast when switched from YPL to SL ( fig. S9A ), but not to the same degree as in npr2D yeast (Fig. 4) .
Finally, there was no evidence of cleavage of Idh1-GFP in wild-type yeast expressing Gtr1-Q65L incubated in SL ( fig. S9B ), suggesting that yeast did not activate autophagy. Thus, genetic activation of Gtr1 produced phenotypes similar to deletion of NPR2 in yeast in SL, suggesting that the metabolic and proliferative changes in npr2D yeast under these conditions depend on Gtr1.
Sch9 controls proliferation in npr2D cells
TORC1 increases translation and proliferation by activating the ribosomal S6 kinase (8) , known as Sch9 in yeast (48) . To determine if Sch9 was required for proliferation of npr2D yeast in SL, we measured the growth of yeast with a deletion of SCH9 (sch9D yeast). We found that double mutant npr2D sch9D yeast grew slower than wild-type, npr2D, or sch9D yeast in SL (Fig. 7A) . Phosphorylation by TORC1 promotes Sch9 activity (48) ; thus, we tested if phosphorylation of Sch9 differed between wildtype and npr2D yeast in SL. We measured the amounts of endogenous Sch9 protein tagged on the C terminus with hemagglutinin (HA). We found that HA immunoreactivity correlated with the phosphorylation state of Sch9 ( fig. S10) . Moreover, exposing wildtype or npr2D yeast grown in YPL to rapamycin decreased the HA immunoreactivity of full-length Sch9 (Fig. 7B) , consistent with inhibition of TORC1 decreasing phosphorylation of Sch9. In addition, we performed chemical cleavage of protein lysates to generate a C-terminal fragment of Sch9 that has previously been used to estimate TORC1-dependent phosphorylation (48) . Rapamycin decreased both the HA immunoreactivity and apparent molecular weight of the C-terminal fragment of Sch9 in wild-type or npr2D yeast in YPL (Fig. 7B) . Furthermore, the HA immunoreactivity of both full-length Sch9 and the C-terminal fragment of Sch9 was increased in npr2D yeast relative to wild-type yeast in both YPL and SL (Fig. 7B) , suggestive of increased phosphorylation. The abundance of Sch9 transcripts did not differ between wild-type and npr2D yeast grown in YPL or SL (Fig. 7C) . Thus, these data suggest that the yeast deficient for Npr2 have hyperactive TORC1 in both rich and minimal media with lactate.
DISCUSSION
As a key regulator of metabolism, the TORC1 pathway balances cell growth with survival (49) . Here, we defined a metabolic and mechanistic basis of how the Npr2 complex, through TORC1, regulates cell growth in a nonfermentable, oxidative carbon source (lactate). The loss of Npr2 resulted in a hyperproliferative metabolic state (Fig. 1) , switching from glutamine accumulation to consumption, thereby supplying cells with nitrogenous metabolites required for proliferation (Figs. 2 and 3 ). Npr2-deficient yeast had increased SAM (Fig. 4) , which can drive cell growth and proliferation through the action of Ppm1-mediated methylation of PP2A (21), and increased transfer RNA thiolation (50) . Our data are consistent with a model in which the loss of Npr2 disrupts the Npr2 complex, relieving Gtr1 inhibition and activating TORC1. TORC1 activation alters both nitrogen and sulfur metabolism to provide building blocks for proliferation, and the increased methylation of PP2A due to high concentrations of SAM drives a feed-forward loop by further inhibiting Npr2 and activating TORC1, thereby promoting growth (Fig. 7D) . Moreover, in wild-type yeast grown in amino acid-free lactate medium, methionine supplementation promoted nitrogen assimilation and consumption of glutamine for nitrogen, recapitulating the metabolic and proliferative phenotypes observed in npr2D yeast (Fig.  4) . This regulation of nitrogen and sulfur amino acid metabolism appears to be critical for switching between proliferation and autophagy. Our studies reveal that the role of the Npr2 complex in regulating nitrogen metabolism, glutamine utilization, and TORC1 activity depends on nutritional context, including the carbon source used by the cells. Previous studies of the yeast Npr2 complex and TORC1 are limited to glucose-rich medium (14, 15, 19, 51) . Under these conditions, npr2D yeast are not adapted to environments where the nitrogen source quality is poor (14) , but grow more normally in the presence of the preferred nitrogen source glutamine (14) . Our investigations were performed in media with a nonfermentable carbon source (lactate), and not glucose. Npr2 is degraded by the F-box ubiquitin ligase Grr1 (glucose repression resistant 1) (15). Grr1 is known to function primarily in glucose catabolite repression (52, 53) , suggesting that the function of Npr2 becomes more important upon glucose depletion or in conditions requiring oxidative metabolism. In such conditions, the absence of Npr2 leads to increased nitrogen consumption and unchecked growth. These diverse observations suggest distinct roles and modes of regulation for Npr2 depending on the nature of the carbon source. Nonetheless, a consensus model emerges in which the Npr2 complex functions to inactivate TORC1 to slow down glutamine consumption and promote glutamine accumulation. In media containing glucose and ammonium, loss of Npr2 function may cause dysregulation of glutamine synthesis and utilization at the expense of other metabolic processes, thus leading to slower growth.
There is considerable interest in the interplay between TORC1 and glutamine in growth regulation. Glutamine, in conjunction with leucine, reportedly activates TORC1 by increasing leucine transport (54) or through glutaminolysis (51, (55) (56) (57) , although the precise mechanisms remain unclear. We showed that in minimal lactate conditions, TORC1 activation through the loss of NPR2 increased glutamine metabolism to synthesize nitrogen-containing metabolites, despite lower intracellular leucine (Fig. 2) . Furthermore, accumulation of glutamine did not correlate with increased TORC1 activity (Figs. 2 and 7) , and supplementation of glutamine did not increase proliferation in wild-type yeast (Fig 4B, fig. S7 ). Thus, glutamine metabolism appears to be downstream of Npr2 complex-Gtr1-TORC1 during such nutrient limitations. We propose a central function of TORC1 in increasing the synthesis and utilization of glutamine as a nitrogen donor for biosynthesis, with a key role of the Npr2 complex in modulating TORC1 activity according to the metabolic need. Finally, studies of cancer cell lines have focused on the utilization of glutamine as a carbon source (28, 58, 59) . However, our results reiterate the importance of glutamine as a nitrogen source for biosynthesis of numerous important metabolites including amino acids, nucleotides, glutathione, and NAD + (34, 38, 39, 60 ) that promote cell proliferation. Therefore, lack of Npr2 function in certain nutritional contexts may cause dysregulations in metabolism that promote transformation. 
MATERIALS AND METHODS
Yeast strains, gene deletion, tagging, and mutagenesis
The prototrophic CEN.PK strain background was used in all experiments. Strains used in this study are listed in table S3. Gene deletions or tagging was performed using a PCR-based strategy as described (61) . The GTR1 coding sequence and TEF1 promoter for overexpression were amplified and inserted into the Sma I site in HO-poly-HygroMX4-HO plasmid (62) . The HO-TEF1p-GTR1 Q65L-HygroMX4-HO plasmid was subsequently made by Site-Directed Mutagenesis, and these constructs were stably expressed at the HO locus in wild-type or npr2D yeast. Standard formulations for rich medium (yeast extract, peptone) or synthetic minimal medium (yeast nitrogen base and ammonium sulfate without amino acids) with 2% concentrations of the specified carbon source were used. The supplemented amino acids were methionine and glutamine (0.5 mM each or as specified), a-ketoglutarate (dimethyl-a-KG, 2 mM), and non-sulfur amino acid (Non-S) mixture containing 1 mM of each amino acid (except Met, Cys, Tyr) or as specified in the text. Unless specified, cells were grown in rich medium with lactate as the carbon source (YPL) for~36 hours with repeated dilutions, to acclimatize cells to growth in lactate, and were subsequently switched to YPL, minimal medium with lactate (SL), or as indicated. Cell proliferation curves in different media used cultures started at an absorbance at 600 nm (A 600 ) of~0.15 to 0.2.
RNA purifications and RT-qPCR
Total RNA from yeast cells was isolated using a MasterPure Yeast RNA kit (Epicentre). Reverse transcription was performed on 1 mg of purified total RNA, using SuperScript II reverse transcriptase (Invitrogen). Quantitative PCR was performed using SYBR Green, validated primers, and template complementary DNA. Transcript abundance was normalized to that for ACT1. The primer sequences used were SCH9: ACTGTCACAAGAGGGGAGGTand TCAAGGCCTCCCAGTCGATA, and ACT1: TCGTTCCAATTTACGCTGGTT and CGGCCAAATCGATTCTCAA.
Cell collection, protein extraction, and detection
Equal numbers of cells were collected from respective cultures; flash-frozen in liquid nitrogen; and lysed in 50 mM NaCl, 100 mM tris (pH 7.5), 1 mM EDTA, 1 mM EGTA, 10% glycerol, 0.5% Triton X-100, 2 mM b-mercaptoethanol, protease inhibitors, and phosphatase inhibitors (50 mM sodium fluoride, 2 mM sodium orthovanadate) by bead-beating with glass beads. Protein concentrations from extracts were measured using a bicinchoninic acid assay. Equal amounts of samples were resolved on 12% or 4 to 12% bis-tris gels and detected as specified. Coomassie blue-stained gels or Western blots for glucose-6-phosphate dehydrogenase (G6PD) were used as loading controls. We used the following primary antibodies: monoclonal FLAG M2 (Sigma), G6PD (Sigma), HA (12CA5, Roche), and GFP (Roche). Horseradish peroxidase-conjugated secondary antibodies (mouse and rabbit) were obtained from Sigma. For Western blotting, standard enhanced chemiluminescence methods were used, with reagents from Thermo Scientific.
Detection of phosphorylated Sch9 by NTCB cleavage
The Sch9 gel mobility shift assay was modified from (48) . Cultures were grown in the specified medium to an A 600 of~1, quenched in 10% trichloroacetic acid, and rapidly harvested by centrifugation. The pellets were flash-frozen and lysed in 300 ml of buffer containing 50 mM tris (pH 7.5), 5 mM EDTA, 6 M urea, 1% SDS, 1 mM phenylmethylsulfonyl fluoride, and protein phosphatase inhibitors (50 mM sodium fluoride, 2 mM sodium orthovanadate) by bead-beating with glass beads, with subsequent heating (10 min, 65°C). Lysates were collected after centrifugation, and protein concentrations were measured and equalized. The chemical cleavage assay with NTCB was performed as described (48) . Further analysis was done by SDS-polyacrylamide gel electrophoresis separation and immunoblotting with the HA antibody. 
Cells for metabolite extractions
Cells were grown in YPL for~36 hours with repeated dilutions, diluted in YPL (A 600 , 0.01), and grown to an A 600 of~1.0; the cells were then collected for metabolite extractions or rapidly harvested and transferred to SL and then collected for metabolite extractions at specified times. Metabolites were extracted in 75% ethanol as described earlier (50, 63) . Acidic extractions (to preserve oxidation-sensitive metabolites) were done in 75% ethanol with 0.1% formic acid.
Metabolite analysis by LC-MS/MS
Extracted metabolites were measured using targeted LC-MS/MS methods, expanding methods described previously (50, 63) . A library of common metabolites was constructed using standards, and metabolites were detected using an AB SCIEX 3200 QTRAP triple quadrupole-linear ion trap mass spectrometer for quantitative optimization detection of daughter ions upon collision-induced fragmentation of the parent ion [multiple reaction monitoring (MRM)]. For each metabolite, parameters for quantitation of the two most abundant daughter ions (that is, two MRMs per metabolite) were included. Metabolites were separated chromatographically using a Synergi Fusion column (150 × 2.0 mm, 4 m, Phenomenex), using a Shimadzu Prominence LC20/SIL-20AC HPLC (high-performance liquid chromatography) autosampler coupled to the mass spectrometer. Buffers for positive-mode analysis were buffer A: 99.9% H 2 O/0.1% formic acid and buffer B: 99.9% methanol/0.1% formic acid (T = 0 min, 0% B; T = 4 min, 0% B; T = 11 min, 50% B; T = 13 min, 100% B; T = 15 min, 100% B, T = 16 min, 0% B; T = 20 min, stop), or buffer A: 5 mM ammonium acetate in H 2 O and buffer B: 5 mM ammonium acetate in 100% methanol. Buffers for negative-mode analysis were 5 mM tributylamine (TBA) (buffer A) and 100% methanol (buffer B). The area under each peak was quantitated by using Analyst software, inspected for accuracy, and normalized against total ion count, after which relative amounts were measured, setting metabolite amounts from wild-type samples in the first time point to 1. 
Hierarchical clustering analysis and heat maps
For hierarchical clustering analysis, the normalized abundances of metabolite were log 2 -transformed, centered about the mean, and clustered by Spearman rank correlation with Cluster software (64, 65) . The data were visualized as heat maps with Java TreeView.
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